NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-269-2010-0-ES-19 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE ES EP 11763819.7 Issued
NCI E-269-2010-0-PT-25 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE PT EP 11763819.7 Issued
NCI E-269-2010-0-NL-24 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE NL EP 11763819.7 Issued
NCI E-269-2010-0-GB-21 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE GB EP 11763819.7 Issued
NCI E-269-2010-0-CH-17 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE CH EP 11763819.7 Issued
NCI E-269-2010-0-JP-07 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE JP National Stage 2013-529285 Issued
NCI E-269-2010-0-CN-06 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE CN National Stage 201180045492.0 Issued
NCI E-269-2010-0-AU-03 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE AU National Stage 2011305817 Issued
NIAID E-324-2005-3-US-03 Conformationally Stabilized HIV Envelope Immunogens US DIV 13/232,775 8268323 Abandoned PDF
NCI E-269-2010-0-PCT-02 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE PCT PCT PCT/US11/51537 Expired
NEI E-233-2010-0-US-01 Dual-function Needle US 61/533,908 Abandoned
NCI E-205-2011-0-US-01 Biomarkers and Therapeutic Targets of Hepatocellular Cancer US 61/533,392 Abandoned
NICHD E-252-2011-0-US-01 Compositions For And Methods of Treatment And Enhanced Detection of Non-Pituitary Tumors US 61/533,664 Abandoned
NIAID E-274-2011-0-US-01 IMMUNOGENS BASED ON AN HIV-1 V1V2 SITE-OF-VULNERABILITY US 61/533,721 Abandoned
NIAID E-124-2009-0-RU-06 Influenza Hemagglutinin And Neuraminidase Variants RU National Stage 2011137404 Abandoned
NICHD E-061-2005-0-US-04 PMNT as a Novel Marker For Progenitor Cells US CON 13/229,236 8614091 Abandoned PDF
NHGRI E-020-2003-1-US-11 LMNA GENE AND ITS INVOLVEMENT IN HUTCHINSON-GILFORD PROGERIA SYNDROME (HGPS) AND ARTERIOSCLEROSIS US CON 13/229,441 8535884 Abandoned PDF
NCI E-188-2010-1-EP-01 Human Monoclonal Antibody Against Human Folate Receptor Beta EP National Stage 18161859.6 Pending
NCI E-188-2010-0-EP-03 Anti-Human Folate Receptor Beta Antibodies And Methods of Use EP National Stage 11824164.5 Abandoned
NCI E-188-2010-0-PCT-02 Anti-Human Folate Receptor Beta Antibodies And Methods of Use PCT PCT PCT/US11/050943 Expired
NIBIB E-079-2011-0-US-01 IMAGING AGENTS FOR IMAGING PROTEASE ACTIVITY AND USES THEREOF US 61/533,014 Abandoned
NCATS E-287-2011-0-US-01 Amido Compounds As RORgt Modulators And Uses Thereof US 61/573,635 Abandoned
NIAID E-208-2011-0-US-01 Tyrosine-Sulfate Mimetics That Inhibit H1V-1 Entry Derived By A Structure Guided Approach, And Their Use As H1V-1 Therapeutics US 61/532,635 Abandoned
NIAID E-238-2012-1-US-01 HIV Inhibitors US 61/532,036 Abandoned
NHGRI E-270-2011-0-US-01 Encapsulated N-acetyl-mannosamine (ManNAc) And N-acetylneuraminic Acid (NANA Or Neu5Ac) To Increase Sialylation US 61/531,934 Abandoned
NIAID E-238-2012-0-US-01 HIV Inhibitors US 61/531,541 Abandoned
NIDCR E-080-2007-0-US-03 Method Of Preventing Survival Of Retrovirally Infected Cells And Of Inhibiting Formation Of Infectious Retrovirus US National Stage 10/581,658 Abandoned
NIDCD E-084-2009-0-US-03 Diagnostic And Therapeutic Uses Of GNPTAB, GNPTG, And NAGPA In Stuttering US National Stage 13/148,340 8530167 Issued PDF
NHLBI E-338-2007-3-US-03 Methods And Apparatus For Creating Particle Derivatives Of HDL With Reduced Lipid Content US CON 13/222,287 8268787 Expired PDF
NHLBI E-048-2009-0-US-03 Tensioning Device And Methods For Use US National Stage 13/254,160 Abandoned
NIA E-275-2011-0-US-01 Tests and Treatment US 61/529,531 Abandoned
NIA E-103-2011-1-US-01 Use of Zscan4 And ZScan4-Dependent Genes For Direct Reprogramming Of Somatic Cells US 61/529,055 Abandoned
NCI E-104-2009-0-JP-05 MicroRNAs in Never-Smokers and Related Materials and Methods JP National Stage 2011-552098 Abandoned
NCI E-025-2011-1-US-01 Antibodies To Tumor Endothelial Marker 8 US 61/527,339 Abandoned
NCI E-104-2009-0-US-07 MicroRNAs in Never-Smokers and Related Materials and Methods US National Stage 13/202,666 Abandoned
CC E-064-2010-0-JP-05 METHOD, SYSTEM AND DEVICES FOR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) PROCEDURES JP National Stage 20110550675 Pending
NCI E-065-2005-4-US-04 NOVOBIOCIN ANALOGUES HAVING MODIFIED SUGAR MOIETIES US National Stage 13/202,382 9120774 Issued PDF
NCI E-065-2005-4-JP-03 NOVOBIOCIN ANALOGUES HAVING MODIFIED SUGAR MOIETIES JP National Stage 2011-551248 Issued
NCI E-251-2011-0-US-01 Gene Expression Predictors of Tumor Responsiveness To Therapy US 61/525,539 Abandoned
NIA E-219-2008-0-US-03 Method for The Diagnosis Of Age-Associated Vascular Disorders US National Stage 13/202,319 Abandoned
NCI E-151-2011-0-US-01 Reduction of TGF-beta Signaling In Myeloid Cells In The Treatment of Cancer US 61/525,025 Abandoned
NCI E-250-2008-0-US-04 Quantitative Oxygen Imaging Systems And Methods Using Echo-based Single Point Imaging US National Stage 13/131,165 8712499 Issued PDF
NIMH E-054-2009-0-US-06 Phosphatidylinositol-3-Kinase P110 Delta-Targeted Drugs In The Treatments Of CNS Disorders US National Stage 13/132,425 Abandoned
NCI E-289-2011-0-US-01 The Ability Of Novel Yeast-MUC1 Constructs To Mature Human Dendritic Cells (DCs) And Activate Human T Cells US 61/524,407 Abandoned
NCATS E-038-2011-0-US-01 Small Molecule Treatment of Ataxia-Telangiectasia or DNA Damage US 61/524,177 Abandoned
NCI E-228-2010-0-AU-03 Methods of Indentifying Central Memory T Cells And Obtaining Antigen-Specific T Cell Populations AU National Stage 2011292248 Abandoned
NCI E-228-2010-0-PCT-02 Methods of Indentifying Central Memory T Cells And Obtaining Antigen-Specific T Cell Populations. PCT PCT PCT/US11/47719 Expired
NCI E-228-2010-0-EP-05 Methods of Indentifying Central Memory T Cells And Obtaining Antigen-Specific T Cell Populations EP National Stage 11746738.1 Abandoned
NCI E-228-2010-0-CA-04 Methods of Indentifying Central Memory T Cells And Obtaining Antigen-Specific T Cell Populations. CA National Stage 2809255 Abandoned
NIDCR E-063-2009-0-US-03 Serological Screening For HHV-8 Infection Using Antigen Mixtures US National Stage 13/201,317 8951723 Issued PDF